US pharma major Bristol-Myers Squibb and BioLabs, a network of shared lab facilities for high-potential life-science start-ups, located in the nation’s key biotech innovation clusters, today announced Bristol-Myers Squibb as the Founding Sponsor of BioLabs’ newest location, BioLabs@NYULangone.
This BioLabs site was launched in partnership with NYU Langone Health.
As part of the agreement, for each year of active sponsorship, Bristol-Myers Squibb can nominate up to three innovative life-sciences and biotech start-up companies per year to take up residence in BioLabs’ facilities at 180 Varick Street in Manhattan.
The nomination process will launch in early 2018.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze